|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in the Netherlands |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
eCompliance - Part 2: The Physician's Perspective
84 pages | Mars 2005 |
IntroductionThe eCompliance market, though immature, is developing rapidly.
The market will continue to grow as novel means of addressing compliance issues through online channels emerge.
Long-t |
3 040,00 €
|
| |
| |
UK Analgesics 2004
12 pages | Juillet 2004 |
Snapdata's UK Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK analgesic market, and covers non |
240,00 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
1 520,00 €
|
| |
| |
Chinese Markets for Drug Delivery Systems
210 pages | Mai 2004 |
China's demand for drug delivery systems has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's ec |
2 835,00 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
2 443,75 €
|
| |
| |
Poland OTC Pharmaceuticals 2004
11 pages | Juillet 2004 |
Snapdata's Poland OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish OTC pharmaceuti |
240,00 €
|
| |
| |
US Acne Treatments 2005
12 pages | Mars 2005 |
Snapdata's US Acne Treatments 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US acne treatments market, and |
240,00 €
|
| |
| |
US Cough Cold & Throat Remedies 2004
16 pages | Juillet 2004 |
Snapdata's US Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough, cold an |
240,00 €
|
| |
| |
UK Hayfever Remedies 2004
13 pages | Juillet 2004 |
Snapdata's UK Hayfever Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK hayfever remedy market, a |
240,00 €
|
| |
| |
US Thermometers 2004
12 pages | Juillet 2004 |
Snapdata's US Thermometers 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US thermometer market, and covers |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in the Netherlands |
|
|
Datamonitor's OTC Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Market shares are covered by manufacturer and/or brand
* Distribution channels are also analyzed
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Competitive Landscape 13
CHAPTER 7 Leading Companies 14
7.1 GlaxoSmithKline Plc 14
7.2 Merck & Co., Inc. 14
7.3 Pfizer Inc 15
CHAPTER 8 Distribution 16
CHAPTER 9 Market Forecasts 17
9.1 Market Value Forecast 17
CHAPTER 10 Macroeconomic Indicators 18
CHAPTER 11 Further Reading 20
11.1 Sources 20
11.2 Related Datamonitor Research 20
LIST OF TABLES
Table 1: Netherlands OTC Pharmaceuticals Market Value: $ million, 2000-2004 9
Table 2: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2004 10
Table 3: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2004 11
Table 4: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2004 12
Table 5: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2004 16
Table 6: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2004-2009 17
Table 7: Netherlands Size of Population (million) , 2000-2004 18
Table 8: Netherlands GDP (1995=100), 2000-2004 18
Table 9: Netherlands Inflation, 2000-2004 18
Table 10: Netherlands Exchange Rate, 2000 19
CONTENTS
|
|
|
PPLSEN
|
|
|
|
|
